关注
Qiu-Xu Teng
Qiu-Xu Teng
其他姓名Qiuxu Teng
在 stjohns.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
JQ Wang, Y Yang, CY Cai, QX Teng, Q Cui, J Lin, YG Assaraf, ZS Chen
Drug Resistance Updates 54, 100743, 2021
1442021
Signaling pathways and therapeutic interventions in gastric cancer
ZN Lei, QX Teng, Q Tian, W Chen, Y Xie, K Wu, Q Zeng, L Zeng, Y Pan, ...
Signal transduction and targeted therapy 7 (1), 358, 2022
962022
ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
JQ Wang, ZX Wu, Y Yang, QX Teng, YD Li, ZN Lei, KA Jani, N Kaushal, ...
Journal of Evidence‐Based Medicine 14 (3), 232-256, 2021
842021
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells
ZX Wu, QX Teng, CY Cai, JQ Wang, ZN Lei, Y Yang, YF Fan, JY Zhang, ...
Biochemical pharmacology 166, 120-127, 2019
592019
Olmutinib (BI1482694/HM61713), a novel epidermal growth factor receptor tyrosine kinase inhibitor, reverses ABCG2-mediated multidrug resistance in cancer cells
W Zhang, YF Fan, CY Cai, JQ Wang, QX Teng, ZN Lei, L Zeng, P Gupta, ...
Frontiers in pharmacology 9, 1097, 2018
562018
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo
AA De Vera, P Gupta, Z Lei, D Liao, S Narayanan, Q Teng, SE Reznik, ...
Cancer letters 442, 91-103, 2019
542019
VS-4718 antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells by inhibiting the efflux function of ABC transporters
N Ji, Y Yang, CY Cai, ZN Lei, JQ Wang, P Gupta, QX Teng, ZS Chen, ...
Frontiers in Pharmacology 9, 1236, 2018
532018
Venetoclax, a BCL-2 inhibitor, enhances the efficacy of chemotherapeutic agents in wild-type ABCG2-overexpression-mediated MDR cancer cells
JQ Wang, JY Li, QX Teng, ZN Lei, N Ji, Q Cui, L Zeng, Y Pan, DH Yang, ...
Cancers 12 (2), 466, 2020
442020
Tivantinib, A c-met inhibitor in clinical trials, is susceptible to ABCG2-mediated drug resistance
ZX Wu, Y Yang, QX Teng, JQ Wang, ZN Lei, JQ Wang, S Lusvarghi, ...
Cancers 12 (1), 186, 2020
422020
Erdafitinib antagonizes ABCB1-mediated multidrug resistance in cancer cells
W Feng, M Zhang, ZX Wu, JQ Wang, XD Dong, Y Yang, QX Teng, ...
Frontiers in oncology 10, 955, 2020
382020
Overexpression of ABCB1 transporter confers resistance to mTOR inhibitor WYE-354 in cancer cells
J Wang, DH Yang, Y Yang, JQ Wang, CY Cai, ZN Lei, QX Teng, ZX Wu, ...
International journal of molecular sciences 21 (4), 1387, 2020
382020
Understanding and targeting resistance mechanisms in cancer
ZN Lei, Q Tian, QX Teng, JND Wurpel, L Zeng, Y Pan, ZS Chen
MedComm 4 (3), e265, 2023
352023
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro
Y Yang, N Ji, QX Teng, CY Cai, JQ Wang, ZX Wu, ZN Lei, S Lusvarghi, ...
Frontiers in oncology 10, 700, 2020
342020
Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells
ZX Wu, Y Yang, G Wang, JQ Wang, QX Teng, L Sun, ZN Lei, L Lin, ...
Cancer Science 111 (8), 2872-2882, 2020
322020
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators
S Wang, SQ Wang, QX Teng, L Yang, ZN Lei, XH Yuan, JF Huo, XB Chen, ...
Journal of Medicinal Chemistry 63 (24), 15979-15996, 2020
302020
Antimicrobial peptide reverses ABCB1-mediated chemotherapeutic drug resistance
X Luo, QX Teng, JY Dong, DH Yang, M Wang, W Dessie, JJ Qin, ZN Lei, ...
Frontiers in Pharmacology 11, 1208, 2020
302020
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor
Y Yang, N Ji, CY Cai, JQ Wang, ZN Lei, QX Teng, ZX Wu, Q Cui, Y Pan, ...
Cancer Communications 40 (7), 285-300, 2020
272020
M3814, a DNA-PK inhibitor, modulates ABCG2-mediated multidrug resistance in lung cancer cells
ZX Wu, Z Peng, Y Yang, JQ Wang, QX Teng, ZN Lei, YG Fu, K Patel, L Liu, ...
Frontiers in Oncology 10, 674, 2020
262020
Revisiting mTOR inhibitors as anticancer agents
QX Teng, YV Ashar, P Gupta, E Gadee, YF Fan, SE Reznik, JND Wurpel, ...
Drug Discovery Today 24 (10), 2086-2095, 2019
262019
Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells
ZN Lei, QX Teng, ZX Wu, FF Ping, P Song, JND Wurpel, ZS Chen
MedComm 2 (4), 765-777, 2021
252021
系统目前无法执行此操作,请稍后再试。
文章 1–20